IR@PKUHSC  > 北京大学第一临床医学院  > 普通外科
学科主题临床医学
A substantial level of donor hematopoietic chimerism is required to protect donor-specific islet grafts in diabetic nod mice.
Guo, Z; Wu, T; Sozen, H; Pan, Y; Heuss, N; Kalscheuer, H; Sutherland, DER; Blazar, BR; Hering, BJ
刊名TRANSPLANTATION
2003-04-15
DOI10.1097/01.TP.0000057832.92231.F5
75期:7页:909-915
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Immunology ; Surgery ; Transplantation
研究领域[WOS]Immunology ; Surgery ; Transplantation
关键词[WOS]REGULATORY T-CELLS ; BONE-MARROW TRANSPLANTATION ; SKIN ALLOGRAFT TOLERANCE ; ALLOGENEIC CHIMERISM ; MIXED CHIMERISM ; AUTOIMMUNE-DISEASES ; INDUCTION ; IMMUNOSUPPRESSION ; MYELOABLATION ; THYMOCYTES
英文摘要

Background. Mixed chimerism can induce tolerance to alloantigens and restore self-tolerance to autoantigens, thereby permitting islet transplantation. However, the minimal level of donor chimerism that is required to prevent islet allograft rejection and recurrence of autoimmune diabetes has not been established.

Methods. We investigated whether allogeneic Balb/c donor chimerism can be induced in C57BL/6 mice, in prediabetic NOD mice, and in diabetic NOD mice after transplantation of a modest dose of bone marrow by using purine nucleoside analogue, fludarabine phosphate and cyclophosphamide conditioning therapy, followed by short-term anti-CD40 ligand monoclonal antibody and rapamycin posttransplant treatment. We also investigated whether the induced donor chimerism is sufficient to prevent the onset of diabetes in prediabetic NOD mice and protect donor islet grafts in diabetic NOD mice.

Results. Allogeneic donor chimerism could be induced under the authors′ approach that is nonmyeloablative and radiation-free. Diabetes onset was prevented in chimeric prediabetic NOD mice. The induction of mixed chimerism protected donor-specific islet grafts in diabetic NOD mice. At 60 days after islet transplantation, all donor Balb/c islet grafts survived in diabetic NOD mice whose level of donor-derived lymphocytes was higher than 30% at the time of islet transplantation (n=8). In contrast, Balb/c islet grafts were rejected in five of seven diabetic NOD mice whose level was lower than 30%.

Conclusions. Our data demonstrate that a donor lymphocyte chimerism (>30%) at the time of islet transplantation is required to protect donor-specific islet grafts, and indicate that a strictly non-irradiation-based protocol can be used to achieve this goal.

语种英语
WOS记录号WOS:000182338500001
引用统计
被引频次:24[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/58560
专题北京大学第一临床医学院_普通外科
作者单位1.Beijing Univ, Hosp 1st, Dept Surg, Beijing, Peoples R China
2.Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA
3.Univ Minnesota, Diabet Inst Immunol & Transplantat, Minneapolis, MN 55455 USA
4.Univ Minnesota, Dept Pediat, Div Bone Marrow Transplantat, Minneapolis, MN 55455 USA
5.Univ Minnesota, Ctr Canc, Minneapolis, MN 55455 USA
推荐引用方式
GB/T 7714
Guo, Z,Wu, T,Sozen, H,et al. A substantial level of donor hematopoietic chimerism is required to protect donor-specific islet grafts in diabetic nod mice.[J]. TRANSPLANTATION,2003,75(7):909-915.
APA Guo, Z.,Wu, T.,Sozen, H.,Pan, Y.,Heuss, N.,...&Hering, BJ.(2003).A substantial level of donor hematopoietic chimerism is required to protect donor-specific islet grafts in diabetic nod mice..TRANSPLANTATION,75(7),909-915.
MLA Guo, Z,et al."A substantial level of donor hematopoietic chimerism is required to protect donor-specific islet grafts in diabetic nod mice.".TRANSPLANTATION 75.7(2003):909-915.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Guo, Z]的文章
[Wu, T]的文章
[Sozen, H]的文章
百度学术
百度学术中相似的文章
[Guo, Z]的文章
[Wu, T]的文章
[Sozen, H]的文章
必应学术
必应学术中相似的文章
[Guo, Z]的文章
[Wu, T]的文章
[Sozen, H]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。